0001213900-21-010577.txt : 20210219 0001213900-21-010577.hdr.sgml : 20210219 20210219161543 ACCESSION NUMBER: 0001213900-21-010577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210217 FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hochman David P CENTRAL INDEX KEY: 0001292834 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38389 FILM NUMBER: 21655767 MAIL ADDRESS: STREET 1: 15 WESTON HILL RD. CITY: RIVERSIDE STATE: CT ZIP: 06878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Motus GI Holdings, Inc. CENTRAL INDEX KEY: 0001686850 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 814042793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 EAST BROWARD BOULEVARD STREET 2: 3RD FLOOR CITY: FT. LAUDERDALE STATE: FL ZIP: 33301 BUSINESS PHONE: 786-459-1831 MAIL ADDRESS: STREET 1: 1301 EAST BROWARD BOULEVARD STREET 2: 3RD FLOOR CITY: FT. LAUDERDALE STATE: FL ZIP: 33301 FORMER COMPANY: FORMER CONFORMED NAME: Eight-Ten Merger Corp. DATE OF NAME CHANGE: 20161006 4 1 ownership.xml X0306 4 2021-02-17 0 0001686850 Motus GI Holdings, Inc. MOTS 0001292834 Hochman David P C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR FT. LAUDERDALE, FL 33301 1 0 0 1 Chairman of the Board Common Stock, par value $0.0001 per share 2021-02-17 4 A 0 40000 0 A 132114 D Common Stock, par value $0.0001 per share 2021-02-17 4 A 0 32472 0 A 164586 D Common Stock, par value $0.0001 per share 2051498 I By Orchestra BioMed, Inc. Common Stock, par value $0.0001 per share 110000 I By DPH 2008 Trust Common Stock, par value $0.0001 per share 16572 I By NSH 2008 Family Trust Stock Option (right to buy) 1.78 2021-02-17 4 A 0 40000 0 A 2031-02-17 Common Stock, par value $0.0001 per share 40000 40000 D On February 17, 2021, Reporting Person was granted 40,000 Common Stock restricted stock units. The restricted stock units vest as to 100% of the shares on February 17, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). On February 17, 2021, Reporting Person was granted 32,472 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2021, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). Reporting Person is a member of the board of directors of Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person jointly exercises dispositive and voting power over the shares owned by OBIO. Reporting Person disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes. The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 100% of the shares on February 17, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. /s/ Andrew Taylor, power of attorney 2021-02-19